As the US is embroiled in a chaotic presidential transition, COVID-19 cases across the country are skyrocketing. Europe is also experiencing a nightmare second wave. But there could be a sign of hope on the horizon. Two companies, Moderna and Pfizer have developed vaccines that are nearly 95% effective. But with many rich countries already scooping up the first orders, that begs the question, what about the rest of us?

Guests

Emanuele Capobianco

Director for Health and Care at IFRC

Torek Farhadi

Former IMF Senior Adviser